Company Encyclopedia
View More
name
Revvity
RVTY.US
Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
757.90 B
RVTY.USMarket value -Rank by Market Cap -/-

Financial Score

13/12/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking22/61
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.04%C
    • Profit Margin8.44%B
    • Gross Margin53.60%B
  • Growth ScoreC
    • Revenue YoY3.37%C
    • Net Profit YoY-6.61%C
    • Total Assets YoY-4.94%D
    • Net Assets YoY-6.89%D
  • Cash ScoreB
    • Cash Flow Margin1184.67%B
    • OCF YoY3.37%C
  • Operating ScoreD
    • Turnover0.23D
  • Debt ScoreB
    • Gearing Ratio39.24%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Revvity Inc. Stock Underperforms Friday When Compared To Competitors

    Revvity Inc.'s stock fell 3.30% to $100.49 on Friday, underperforming compared to competitors like Danaher Corp., IDEXX Laboratories, and Agilent Technologies. The stock's decline ended a two-day winning streak and was part of a broader market downturn, with the S&P 500 and Dow Jones also falling. Revvity's stock is 21.67% below its 52-week high. Trading volume was below the 50-day average.

    Dow Jones·
    US
    RVTY
    -3.30%
    Dow Jones·
    US
    RVTY
    -3.30%

    Federated Hermes Inc. Cuts Position in Revvity Inc. $RVTY

    Federated Hermes Inc. reduced its stake in Revvity Inc. by 9.5% in Q2, owning 213,182 shares worth $20.6M. Other investors adjusted their holdings, with 86.65% of Revvity owned by institutions. Analysts have mixed ratings, with a consensus "Hold" and an average price target of $113.08. Revvity's stock opened at $98.85, with a market cap of $11.21B. The company reported Q3 earnings of $1.18 per share, beating estimates. A quarterly dividend of $0.07 per share was announced.

    Market Beat·
    US
    FHI
    -0.61%
    US
    RVTY
    -3.30%
    Market Beat·
    US
    FHI
    -0.61%
    US
    RVTY
    -3.30%

    Revvity Inc. Stock Underperforms Tuesday When Compared To Competitors

    Revvity Inc. (RVTY) shares fell 1.01% to $98.78 on Tuesday, marking the fourth consecutive day of losses. The stock is 23% below its 52-week high of $128.29. Compared to competitors, Danaher Corp. fell 0.56%, IDEXX Laboratories Inc. fell 1.07%, and Agilent Technologies Inc. fell 1.26%. Trading volume was significantly below the 50-day average.

    Dow Jones·
    US
    RVTY
    -3.30%
    Dow Jones·
    US
    RVTY
    -3.30%

    Revvity Inc. (NYSE:RVTY) Given Consensus Rating of "Moderate Buy" by Analysts

    Revvity Inc. (NYSE:RVTY) has a consensus "Moderate Buy" rating from 14 analysts, with an average price target of $114.75. Recent analyst actions include Barclays raising its target to $105 and Robert W. Baird to $123. The stock opened at $100.81, with a market cap of $11.43 billion. Revvity reported Q3 earnings of $1.18 per share, beating estimates. The company announced a $1 billion stock buyback program.

    Market Beat·
    US
    RVTY
    -3.30%
    Market Beat·
    US
    RVTY
    -3.30%

    PTC Inc. Stock Underperforms Friday When Compared To Competitors

    PTC Inc.'s stock fell 2.79% to $173.52 on Friday, underperforming compared to competitors like Autodesk, Synopsys, and Cadence Design Systems, which saw gains. This decline ended a three-day winning streak for PTC Inc., leaving it 21.02% below its 52-week high. Trading volume was significantly higher than the 50-day average.

    Dow Jones·
    US
    PTC
    -1.12%
    Dow Jones·
    US
    PTC
    -1.12%
    © 2025 Longbridge｜Disclaimer